ELECTROCORE INC (ECOR) Stock Fundamental Analysis
USA - NASDAQ:ECOR - US28531P2020 - Common Stock
4.9 USD
-0.08 (-1.61%)
Overall ECOR gets a fundamental rating of 3 out of 10. We evaluated ECOR against 189 industry peers in the Health Care Equipment & Supplies industry. The financial health of ECOR is average, but there are quite some concerns on its profitability. ECOR shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year ECOR has reported negative net income.
ECOR had a negative operating cash flow in the past year.
ECOR had negative earnings in each of the past 5 years.
In the past 5 years ECOR always reported negative operating cash flow.
1.2 Ratios
ECOR has a worse Return On Assets (-91.02%) than 77.25% of its industry peers.
ECOR has a Return On Equity of -1190.57%. This is amonst the worse of the industry: ECOR underperforms 87.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -91.02% | ||
| ROE | -1190.57% | ||
| ROIC | N/A |
ROA(3y)-88.18%
ROA(5y)-75.86%
ROE(3y)-180.1%
ROE(5y)-137.89%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 85.52%, ECOR belongs to the best of the industry, outperforming 95.77% of the companies in the same industry.
In the last couple of years the Gross Margin of ECOR has grown nicely.
ECOR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 85.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y10.55%
2. Health
2.1 Basic Checks
ECOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
ECOR has more shares outstanding than it did 1 year ago.
ECOR has more shares outstanding than it did 5 years ago.
ECOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -16.97, we must say that ECOR is in the distress zone and has some risk of bankruptcy.
ECOR's Altman-Z score of -16.97 is on the low side compared to the rest of the industry. ECOR is outperformed by 87.83% of its industry peers.
ECOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -16.97 |
ROIC/WACCN/A
WACC8.66%
2.3 Liquidity
ECOR has a Current Ratio of 1.10. This is a normal value and indicates that ECOR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ECOR (1.10) is worse than 86.77% of its industry peers.
A Quick Ratio of 0.95 indicates that ECOR may have some problems paying its short term obligations.
ECOR has a Quick ratio of 0.95. This is in the lower half of the industry: ECOR underperforms 78.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.03% over the past year.
The Revenue has grown by 30.15% in the past year. This is a very strong growth!
The Revenue has been growing by 60.15% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)26.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
Revenue 1Y (TTM)30.15%
Revenue growth 3Y66.56%
Revenue growth 5Y60.15%
Sales Q2Q%20.23%
3.2 Future
The Earnings Per Share is expected to grow by 28.31% on average over the next years. This is a very strong growth
ECOR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.40% yearly.
EPS Next Y-3.65%
EPS Next 2Y25.65%
EPS Next 3Y28.31%
EPS Next 5YN/A
Revenue Next Year21.64%
Revenue Next 2Y31.43%
Revenue Next 3Y32.39%
Revenue Next 5Y27.4%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ECOR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ECOR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as ECOR's earnings are expected to grow with 28.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.65%
EPS Next 3Y28.31%
5. Dividend
5.1 Amount
ECOR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ECOR (10/27/2025, 6:16:24 PM)
4.9
-0.08 (-1.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners15.51%
Inst Owner Change0%
Ins Owners28.29%
Ins Owner Change2.02%
Market Cap38.91M
Revenue(TTM)27.70M
Net Income(TTM)-13251000
Analysts84
Price Target21.5 (338.78%)
Short Float %7.18%
Short Ratio7
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.74%
Min EPS beat(2)-40.66%
Max EPS beat(2)1.19%
EPS beat(4)2
Avg EPS beat(4)-14.48%
Min EPS beat(4)-40.66%
Max EPS beat(4)9.28%
EPS beat(8)6
Avg EPS beat(8)-2.43%
EPS beat(12)6
Avg EPS beat(12)-5.19%
EPS beat(16)7
Avg EPS beat(16)-4%
Revenue beat(2)1
Avg Revenue beat(2)-1.44%
Min Revenue beat(2)-3.11%
Max Revenue beat(2)0.24%
Revenue beat(4)1
Avg Revenue beat(4)-1.48%
Min Revenue beat(4)-3.11%
Max Revenue beat(4)0.24%
Revenue beat(8)5
Avg Revenue beat(8)4.24%
Revenue beat(12)6
Avg Revenue beat(12)1.36%
Revenue beat(16)8
Avg Revenue beat(16)1.08%
PT rev (1m)0%
PT rev (3m)0.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-56.58%
EPS NY rev (1m)0.53%
EPS NY rev (3m)-32.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)-0.6%
Revenue NY rev (3m)0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.4 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 34.96 | ||
| P/tB | 34.96 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.62
EYN/A
EPS(NY)-0.68
Fwd EYN/A
FCF(TTM)-0.96
FCFYN/A
OCF(TTM)-0.96
OCFYN/A
SpS3.49
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -91.02% | ||
| ROE | -1190.57% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 85.52% | ||
| FCFM | N/A |
ROA(3y)-88.18%
ROA(5y)-75.86%
ROE(3y)-180.1%
ROE(5y)-137.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y10.55%
F-Score4
Asset Turnover1.9
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | -16.97 |
F-Score4
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
EPS Next Y-3.65%
EPS Next 2Y25.65%
EPS Next 3Y28.31%
EPS Next 5YN/A
Revenue 1Y (TTM)30.15%
Revenue growth 3Y66.56%
Revenue growth 5Y60.15%
Sales Q2Q%20.23%
Revenue Next Year21.64%
Revenue Next 2Y31.43%
Revenue Next 3Y32.39%
Revenue Next 5Y27.4%
EBIT growth 1Y10.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year83.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.33%
OCF growth 3YN/A
OCF growth 5YN/A
ELECTROCORE INC / ECOR FAQ
What is the fundamental rating for ECOR stock?
ChartMill assigns a fundamental rating of 3 / 10 to ECOR.
What is the valuation status of ELECTROCORE INC (ECOR) stock?
ChartMill assigns a valuation rating of 1 / 10 to ELECTROCORE INC (ECOR). This can be considered as Overvalued.
What is the profitability of ECOR stock?
ELECTROCORE INC (ECOR) has a profitability rating of 1 / 10.
How financially healthy is ELECTROCORE INC?
The financial health rating of ELECTROCORE INC (ECOR) is 4 / 10.